ODDB.org: Open Drug Database

Swissmedic Registration	61283	Date of registration	29.06.2010
Company name	Opella Healthcare Switzerland AG	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)		Revocation Date
Index Therapeuticus (Swissmedic)	07.13.10.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Telfastin 120	überzogene Tabletten	überzogene Tabletten (Fexofenadine Hydrochloride 120 mg)	R06AX26	CI
02	Telfastin 180	überzogene Tabletten	überzogene Tabletten (Fexofenadine Hydrochloride 180 mg)	R06AX26	CI

2025	©ywesee GmbH